Which patients with oligometastatic prostate cancer should be considered for cytoreductive radical prostatectomy as part of a multimodal treatment? Results from a large, multi-institutional collaboration
Keyword(s):
2004 ◽
Vol 13
(1)
◽
pp. 39-46
◽
2003 ◽
Vol 8
(2)
◽
pp. 291-295
◽
2019 ◽
Vol 201
(Supplement 4)
◽